Renaissance Capital logo

ANPC News

US IPO Week Ahead: Chinese EVs and US tax software lead a diverse 7 IPO week

VERX

Seven IPOs and one SPAC plan to raise $2.1 billion in the week ahead, led by tax software provider Vertex (VERX). A handful of companies could join the IPO calendar in the coming week, including leading mortgage lender Rocket Companies (RKT), cloud hosting service provider Rackspace (RXT), and health center chain Oak Street Health (OSH). ...read more

US IPO Week Ahead: One biotech to close out February

PASG

Preclinical biotech Passage Bio (PASG) is the only IPO set to price in the coming week. Passage Bio plans to raise $126 million by offering 7.4 million shares at a price range of $16 to $18. At the midpoint, Passage Bio would command a market cap of $713 million. The Pennsylvania-based company was formed by OrbiMed, Frazier Healthcare, and UPenn’s Gene...read more

US IPO Weekly Recap: One Medical pops 58 percent in 5-IPO week

ONEM

Five companies entered the public market this past week. The health clinic unicorn One Medical (ONEM) posted a 57.6% gain and was joined by titan of tin foil Reynolds Consumer Products (REYN), Black Diamond Therapeutics (BDTX), Arcutis Biotherapeutics (ARQT), and AnPac Bio-Medical Science (ANPC) One Medical (ONEM) priced at the low end of the range to raise $245...read more

Chinese diagnostics company AnPac Bio-Medical Science prices US IPO at $12, the low end of the range

ANPC

AnPac Bio-Medical Science, a Chinese provider of multi-cancer screening tests, raised $16 million by offering 1.3 million ADSs at $12, the low end of the range of $12 to $14. The company originally planned to offer 1.7 million ADSs. Each ADS represents one Class A ordinary share of the company. AnPac Bio-Medical Science plans to list on the Nasdaq under the symbol ANPC. WestPark...read more